tv3326 has been researched along with latrepirdine in 1 studies
| Studies (tv3326) | Trials (tv3326) | Recent Studies (post-2010) (tv3326) | Studies (latrepirdine) | Trials (latrepirdine) | Recent Studies (post-2010) (latrepirdine) |
|---|---|---|---|---|---|
| 15 | 0 | 11 | 126 | 7 | 59 |
| Protein | Taxonomy | tv3326 (IC50) | latrepirdine (IC50) |
|---|---|---|---|
| Cholinesterase | Homo sapiens (human) | 7.9 | |
| Histamine H1 receptor | Homo sapiens (human) | 0.8695 | |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 1.58 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.98 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 1.58 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 1.58 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 1.58 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 1.58 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 1.58 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 1.58 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, S; Guan, J; Lin, JP; Liu, XH; Wang, T; Wu, MB; Yang, LR | 1 |
1 review(s) available for tv3326 and latrepirdine
| Article | Year |
|---|---|
Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Cholinesterase Inhibitors; Drug Discovery; Humans; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents | 2019 |